FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2765646098> ?p ?o ?g. }

• W2765646098 endingPage "2175" @default.
• W2765646098 startingPage "2168" @default.
• W2765646098 abstract "Abstract Venous thromboembolism (VTE) is more frequent in infants than in older children. Treatment guidelines in children are adapted from adult VTE data, but do not currently include direct oral anticoagulant use. Dabigatran etexilate (DE) use in the paediatric population with VTE therefore requires verification. We investigated the pharmacokinetic/pharmacodynamic (PK/PD) relationship, safety and tolerability of DE oral liquid formulation (OLF) in infants with VTE (aged < 12 months) who had completed standard anticoagulant treatment in an open-label, phase IIa study. Patients received a single-dose of DE OLF (based on an age- and weight-adjusted nomogram) yielding an exposure comparable to 150 mg in adults. The PK end point was plasma concentration of total dabigatran; PD end points included activated partial thromboplastin time (aPTT), ecarin clotting time (ECT) and diluted thrombin time (dTT). Safety end points included incidence of all bleeding and other adverse events (AEs). Ten patients were screened; eight entered the study (age range, 41–169 days). The geometric mean (gMean) total dabigatran plasma concentrations 2 hours post-dose (around peak concentrations) were 120 ng/mL with a geometric coefficient of variation (gCV) of 62.1%. The gMean at 12 hours post-dosing was 60.4 ng/mL (gCV 30%). PK/PD relationship was linear for ECT and dTT (R 2 = 0.858 and 0.920, respectively), while total dabigatran concentration and aPTT showed a non-linear correlation. There were no deaths, treatment discontinuations or treatment-related AEs. In conclusion, DE was well tolerated without any treatment-related AEs in infants. The observed PK/PD relationships were comparable with the established profile in older patients with VTE." @default.
• W2765646098 created "2017-11-10" @default.
• W2765646098 creator A5004135258 @default.
• W2765646098 creator A5013609146 @default.
• W2765646098 creator A5016763799 @default.
• W2765646098 creator A5025552397 @default.
• W2765646098 creator A5028711269 @default.
• W2765646098 creator A5045161976 @default.
• W2765646098 creator A5047359258 @default.
• W2765646098 creator A5051881642 @default.
• W2765646098 creator A5062801050 @default.
• W2765646098 creator A5066197445 @default.
• W2765646098 creator A5078007913 @default.
• W2765646098 creator A5078483717 @default.
• W2765646098 creator A5088928765 @default.
• W2765646098 date "2017-01-01" @default.
• W2765646098 modified "2023-10-01" @default.
• W2765646098 title "Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism" @default.
• W2765646098 cites W1523598805 @default.
• W2765646098 cites W1564175447 @default.
• W2765646098 cites W1770147359 @default.
• W2765646098 cites W181091954 @default.
• W2765646098 cites W1860085984 @default.
• W2765646098 cites W1977047582 @default.
• W2765646098 cites W1978051825 @default.
• W2765646098 cites W1995194374 @default.
• W2765646098 cites W2012089548 @default.
• W2765646098 cites W2021776778 @default.
• W2765646098 cites W2031581415 @default.
• W2765646098 cites W2034305061 @default.
• W2765646098 cites W2062946016 @default.
• W2765646098 cites W2088996598 @default.
• W2765646098 cites W2106459062 @default.
• W2765646098 cites W2112378432 @default.
• W2765646098 cites W2118092611 @default.
• W2765646098 cites W2120416054 @default.
• W2765646098 cites W2134430286 @default.
• W2765646098 cites W2136489990 @default.
• W2765646098 cites W2139716972 @default.
• W2765646098 cites W2140069482 @default.
• W2765646098 cites W2153657731 @default.
• W2765646098 cites W2155546492 @default.
• W2765646098 cites W2163672737 @default.
• W2765646098 cites W2171677057 @default.
• W2765646098 cites W2476139630 @default.
• W2765646098 cites W2497721881 @default.
• W2765646098 cites W2624994883 @default.
• W2765646098 cites W2184876726 @default.
• W2765646098 doi "https://doi.org/10.1160/th17-06-0429" @default.
• W2765646098 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29202215" @default.
• W2765646098 hasPublicationYear "2017" @default.
• W2765646098 type Work @default.
• W2765646098 sameAs 2765646098 @default.
• W2765646098 citedByCount "26" @default.
• W2765646098 countsByYear W27656460982018 @default.
• W2765646098 countsByYear W27656460982019 @default.
• W2765646098 countsByYear W27656460982020 @default.
• W2765646098 countsByYear W27656460982021 @default.
• W2765646098 countsByYear W27656460982022 @default.
• W2765646098 countsByYear W27656460982023 @default.
• W2765646098 crossrefType "journal-article" @default.
• W2765646098 hasAuthorship W2765646098A5004135258 @default.
• W2765646098 hasAuthorship W2765646098A5013609146 @default.
• W2765646098 hasAuthorship W2765646098A5016763799 @default.
• W2765646098 hasAuthorship W2765646098A5025552397 @default.
• W2765646098 hasAuthorship W2765646098A5028711269 @default.
• W2765646098 hasAuthorship W2765646098A5045161976 @default.
• W2765646098 hasAuthorship W2765646098A5047359258 @default.
• W2765646098 hasAuthorship W2765646098A5051881642 @default.
• W2765646098 hasAuthorship W2765646098A5062801050 @default.
• W2765646098 hasAuthorship W2765646098A5066197445 @default.
• W2765646098 hasAuthorship W2765646098A5078007913 @default.
• W2765646098 hasAuthorship W2765646098A5078483717 @default.
• W2765646098 hasAuthorship W2765646098A5088928765 @default.
• W2765646098 hasConcept C111113717 @default.
• W2765646098 hasConcept C112705442 @default.
• W2765646098 hasConcept C126322002 @default.
• W2765646098 hasConcept C197934379 @default.
• W2765646098 hasConcept C2776301958 @default.
• W2765646098 hasConcept C2776710957 @default.
• W2765646098 hasConcept C2777288759 @default.
• W2765646098 hasConcept C2778261982 @default.
• W2765646098 hasConcept C2778375690 @default.
• W2765646098 hasConcept C2778382381 @default.
• W2765646098 hasConcept C2778810321 @default.
• W2765646098 hasConcept C2779161974 @default.
• W2765646098 hasConcept C2780077467 @default.
• W2765646098 hasConcept C2908647359 @default.
• W2765646098 hasConcept C42219234 @default.
• W2765646098 hasConcept C71924100 @default.
• W2765646098 hasConcept C99454951 @default.
• W2765646098 hasConceptScore W2765646098C111113717 @default.
• W2765646098 hasConceptScore W2765646098C112705442 @default.
• W2765646098 hasConceptScore W2765646098C126322002 @default.
• W2765646098 hasConceptScore W2765646098C197934379 @default.
• W2765646098 hasConceptScore W2765646098C2776301958 @default.
• W2765646098 hasConceptScore W2765646098C2776710957 @default.
• W2765646098 hasConceptScore W2765646098C2777288759 @default.

• next